Ambulatory Blood Pressure-Lowering Effects of Valsartan and Enalapril After a Missed Dose in Previously Untreated Patients with Hypertension : A Prospective, Randomized, Open-Label, Blinded End-Point TrialHERMIDA, Ramon C; AYALA, Diana E; KHDER, Yasser et al.Clinical therapeutics. 2008, Vol 30, Num 1, pp 108-120, issn 0149-2918, 13 p.Article

Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors : The VAST studyRUILOPE, Luis M; MALACCO, Ettore; KHDER, Yasser et al.Clinical therapeutics. 2005, Vol 27, Num 5, pp 578-587, issn 0149-2918, 10 p.Article

Antihypertensive efficacy and tolerability of two fixed- dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension : An 8-week, randomized, double-blind, parallel-group trialLACOURCIERE, Yves; POIRIER, Luc; HEBERT, Daniel et al.Clinical therapeutics. 2005, Vol 27, Num 7, pp 1013-1021, issn 0149-2918, 9 p.Article

Effect of small angiokinase inhibitor nintedanib (BIBF 1120) on QT interval in patients with previously untreated, advanced renal cell cancer in an open-label, phase II studyEISEN, Tim; SHPARYK, Yaroslav; BONDARENKO, Igor et al.Investigational new drugs. 2013, Vol 31, Num 5, pp 1283-1293, issn 0167-6997, 11 p.Article